Drug Profile
Dotarizine
Alternative Names: Dotaricin; FI 6026Latest Information Update: 12 Dec 2006
Price :
$50
*
At a glance
- Originator Ferrer
- Developer Azwell; Ferrer; Kayaku; Mylan Laboratories
- Class Antimigraines; Piperazines
- Mechanism of Action Calcium channel antagonists; Serotonin 1C receptor antagonists; Serotonin 5-HT2 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Migraine; Stroke; Vertigo
Most Recent Events
- 18 Jan 2001 Discontinued-II for Migraine in USA (Unknown route)
- 18 Jan 2001 Discontinued-III for Migraine in Switzerland (Unknown route)
- 18 Jan 2001 Discontinued-Preclinical for Migraine in Canada (Unknown route)